WallStreetZenWallStreetZen

NASDAQ: RKDA
Arcadia Biosciences Revenue

OverviewForecastEarningsRevenue
DividendOwnership
Arcadia Biosciences revenue was $4.76M for the trailing 12 months ending Mar 31, 2026, with N/A growth year over year. Quarterly revenue for the quarter (Q1 2026) ending on Mar 31, 2026 was $1.1M, up 22.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, RKDA annual revenue was $4.9M, with -3.7% growth year-over-year.

RKDA past revenue growth

How has RKDA's revenue growth performed historically?

Company
-9.53%
Industry
3.41%
Market
34.75%
RKDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RKDA's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RKDA's revenue growth is accelerating... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RKDA revenue history

Current Revenue
$4.8M
Current Earnings
-$9.3M
Current Profit Margin
-195.9%

Be the first to know when RKDA announces revenue.

RKDA Revenue History By Year

RKDA Yearly RevenueRKDA RevenueRKDA ChangeRKDA Revenue Growth
2025-12-31$4.86M-$187.00k-3.71%
2024-12-31$5.05M$591.00k+13.27%
2023-12-31$4.45M-$2.96M-39.96%
2022-12-31$7.42M$638.00k+9.41%
2021-12-31$6.78M-$1.25M-15.61%
2020-12-31$8.03M$6.87M+587.25%
2019-12-31$1.17M-$295.00k-20.15%
2018-12-31$1.46M-$2.56M-63.64%
2017-12-31$4.03M$838.00k+26.29%
2016-12-31$3.19M-$2.23M-41.12%
2015-12-31$5.41M-$1.57M-22.46%
2014-12-31$6.98M$504.00k+7.78%
2013-12-31$6.48MN/AN/A

1 of 1

Arcadia Biosciences Revenue FAQ

What was RKDA's revenue last quarter?

Arcadia Biosciences (NASDAQ: RKDA) reported Q1 2026 revenue of $1.10 million up 8.33% year over year. In the same quarter last year, Arcadia Biosciences's revenue was $1.20 million.

What was Arcadia Biosciences's revenue in 2025?

Arcadia Biosciences's annual revenue for the twelve months ending Dec 31, 2025 was $4.86 million, a 3.71% decrease year over year.

How much does Arcadia Biosciences make in a day?

Based on Arcadia Biosciences annual revenue for the past five years, RKDA makes an average of $15,646.58 per day.

What was Arcadia Biosciences's annual revenue growth in the past year?

As of Q2 2026, Arcadia Biosciences's revenue has grown -9.53% year over year. This is 12.94 percentage points lower than the US Packaged Foods industry revenue growth rate of 3.41%. Arcadia Biosciences's revenue in the past year totaled $4.76 million.

How much does Arcadia Biosciences make in a year?

Arcadia Biosciences's revenue by year for the past five years is:
  • Arcadia Biosciences's revenue for the twelve months ending Dec 31, 2025 was $4.86 million, a 3.71% decrease year over year.
  • Arcadia Biosciences's annual revenue for Dec 31, 2024 was $5.05 million, a 13.27% increase from 2023.
  • Arcadia Biosciences's annual revenue for 2023 was $4.45 million, a 39.96% decrease from 2022.
  • Arcadia Biosciences's annual revenue for 2022 was $7.42 million, a 9.41% increase from 2021.
  • Arcadia Biosciences's annual revenue for 2021 was $6.78 million, a 15.61% decrease from 2020.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.